Millions of people inject the new “miraculous” weight loss drugs targeting Glucagon-like peptide-1 (GLP-1) such as Wegovy, Ozempic, and Mounjaro. In mere years after the launch of these drugs, their health benefits became apparent. Obese people started rapidly losing weight, and multiple studies demonstrated the reduction of risk of chronic diseases. The hype around these […]

Author